DE1398266U - - Google Patents

Info

Publication number
DE1398266U
DE1398266U DENDAT1398266D DE1398266DU DE1398266U DE 1398266 U DE1398266 U DE 1398266U DE NDAT1398266 D DENDAT1398266 D DE NDAT1398266D DE 1398266D U DE1398266D U DE 1398266DU DE 1398266 U DE1398266 U DE 1398266U
Authority
DE
Germany
Prior art keywords
ltcr
voi
dio
ßchcnm
vrirc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1398266D
Other languages
German (de)
English (en)
Publication of DE1398266U publication Critical patent/DE1398266U/de
Active legal-status Critical Current

Links

Landscapes

  • Detergent Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DENDAT1398266D Active DE1398266U (enrdf_load_stackoverflow)

Publications (1)

Publication Number Publication Date
DE1398266U true DE1398266U (enrdf_load_stackoverflow)

Family

ID=709460

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1398266D Active DE1398266U (enrdf_load_stackoverflow)

Country Status (1)

Country Link
DE (1) DE1398266U (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
Andersson et al. Subacute pulmonary failure complicating therapy with high‐dose Ara‐C in acute leukemia
Kayama et al. Management of pilocytic astrocytoma
DE1398266U (enrdf_load_stackoverflow)
CURRAN et al. Tolerance to chemotherapy after prior irradiation for Hodgkin's disease
Baab et al. Using modern human cortical bone distribution to test the systemic robusticity hypothesis
US2046859A (en) Automobile bus
Wendt et al. Accelerated split-course radiotherapy and simultaneous cis-dichlorodiammine-platinum and 5-fluorouracil chemotherapy with folinic acid enhancement for unresectable carcinoma of the head and neck
Armitage Long-term toxicity of the treatment of Hodgkin’s disease
DE2735780A1 (de) Verfahren und vorrichtung zum ueberpruefen der personen, die zu einem schleusenraum als bestandteil einer einem erhoehten sicherheitsbeduerfnis unterliegenden anlage zugangsberechtigt sind
DE102005046539A1 (de) Methode zur Behandlung von Krebs- oder Kachexiepatienten mit einem Herzschrittmacher
DeGiovanni et al. Treatment of acute lymphoblastic leukaemia
KOONIN Findings in 300 patients with facial lacerations
Aston New Isotopes of Strontium and Barium
USD8998S (en) Design for side windows of coaches
Wahl et al. Über die Hölderstetigkeit schwacher Lösungen semilinearer elliptischer Systeme mit einseitiger Bedingung.
Marshall OMB Stalks the" Burgeoning Growth of Biomedicine" For decades, NIH has received more money than the President wanted to spend; OMB's assault on this tradition has not even chipped the edges
DE1444755U (enrdf_load_stackoverflow)
Gyselen Rifampicin in Retreatment and
Seligman Acromegaly among the old Northmen
Meserve Chief Coleman Cole
Weichselbaum et al. Radiotherapy failure is associated with inherent cellular radioresistance
Wall et al. Influence of lymph nodal status on primary tumor control probability in head and neck cancer
Baldwin et al. Immediate and delayed mandibular reconstruction
Kelly From the Secretary-Treasurer's Office
Fregene et al. Larynxkarzinome